Clarinol® CLA is a natural ingredient for weight management that has been shown to help reshape bodies by reducing body fat and building lean muscle mass in 8 to 12 weeks when combined with a balanced diet and exercise program.‡
Clarinol® CLA has been scientifically proven to help reduce body fat, increase lean muscle mass and aid in weight management, in combination with exercise and a healthy diet.‡
To achieve the optimal fat reduction and increased lean muscle mass benefits from Clarinol® CLA, it is best to consume 3g per day as part of a healthy diet and lifestyle.‡
With a balanced diet and exercise, Clarinol® CLA helps improve body composition by reducing body fat, while building and maintaining lean muscle tissue, in 8-12 weeks.‡
Warning: If you are pregnant or lactating woman, have any health conditions, or are taking any medication, make sure to consult your healthcare provider prior to use.
‡ These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent any disease.
Ingredients
Dosage
One softgel capsule three times daily.
Count
90 Softgel Capsules
Science
Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000 Dec;130(12):2943-8. doi: 10.1093/jn/130.12.2943. PMID: 11110851.
den Hartigh LJ. Conjugated Linoleic Acid Effects on Cancer, Obesity, and Atherosclerosis: A Review of Pre-Clinical and Human Trials with Current Perspectives. Nutrients. 2019 Feb 11;11(2):370. doi: 10.3390/nu11020370. PMID: 30754681; PMCID: PMC6413010.
Asuka AKAHOSHI, Yuki GOTO, Kayoko MURAO, Tomoko MIYAZAKI, Masao YAMASAKI, Michiko NONAKA, Koji YAMADA, Michihiro SUGANO, Conjugated Linoleic Acid Reduces Body Fats and Cytokine Levels of Mice, Bioscience, Biotechnology, and Biochemistry, Volume 66, Issue 4, 1 January 2002, Pages 916–920, https://doi.org/10.1271/bbb.66.916
Dale A.SchoellerD.A. Schoeller, Abigail C.WatrasA.C. Watras, and Leah D.WhighamL.D. Whigham. 2009. A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Applied Physiology, Nutrition, and Metabolism. 34(5): 975-978. https://doi.org/10.1139/H09-080
DeLany, James P., et al. “Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake.” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 276.4 (1999): R1172-R1179.
Gaullier J-M, Halse J, Hoye K, Kristiansen K, Berven G, Blankson H and Gudmundsen O. Conjugated linoleic acid (CLA) supplementation for one year reduces body fat mass in healthy, overweight humans. Am J of Clin Nutrition, 2004; 79(6):1118–1125.
Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord. 2003 Jul;27(7):840-7. doi: 10.1038/sj.ijo.0802304. PMID: 12821971.
Features :
Hygienic Product : Not Specified
Allergy : Not Specified
Clarinol® CLA - 492
Description
Clarinol® CLA is a natural ingredient for weight management that has been shown to help reshape bodies by reducing body fat and building lean muscle mass in 8 to 12 weeks when combined with a balanced diet and exercise program.‡
Clarinol® CLA has been scientifically proven to help reduce body fat, increase lean muscle mass and aid in weight management, in combination with exercise and a healthy diet.‡
To achieve the optimal fat reduction and increased lean muscle mass benefits from Clarinol® CLA, it is best to consume 3g per day as part of a healthy diet and lifestyle.‡
With a balanced diet and exercise, Clarinol® CLA helps improve body composition by reducing body fat, while building and maintaining lean muscle tissue, in 8-12 weeks.‡
Warning: If you are pregnant or lactating woman, have any health conditions, or are taking any medication, make sure to consult your healthcare provider prior to use.
‡ These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent any disease.
Ingredients
Dosage
One softgel capsule three times daily.
Count
90 Softgel Capsules
Science
Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000 Dec;130(12):2943-8. doi: 10.1093/jn/130.12.2943. PMID: 11110851.
den Hartigh LJ. Conjugated Linoleic Acid Effects on Cancer, Obesity, and Atherosclerosis: A Review of Pre-Clinical and Human Trials with Current Perspectives. Nutrients. 2019 Feb 11;11(2):370. doi: 10.3390/nu11020370. PMID: 30754681; PMCID: PMC6413010.
Asuka AKAHOSHI, Yuki GOTO, Kayoko MURAO, Tomoko MIYAZAKI, Masao YAMASAKI, Michiko NONAKA, Koji YAMADA, Michihiro SUGANO, Conjugated Linoleic Acid Reduces Body Fats and Cytokine Levels of Mice, Bioscience, Biotechnology, and Biochemistry, Volume 66, Issue 4, 1 January 2002, Pages 916–920, https://doi.org/10.1271/bbb.66.916
Dale A.SchoellerD.A. Schoeller, Abigail C.WatrasA.C. Watras, and Leah D.WhighamL.D. Whigham. 2009. A meta-analysis of the effects of conjugated linoleic acid on fat-free mass in humans. Applied Physiology, Nutrition, and Metabolism. 34(5): 975-978. https://doi.org/10.1139/H09-080
DeLany, James P., et al. “Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake.” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 276.4 (1999): R1172-R1179.
Gaullier J-M, Halse J, Hoye K, Kristiansen K, Berven G, Blankson H and Gudmundsen O. Conjugated linoleic acid (CLA) supplementation for one year reduces body fat mass in healthy, overweight humans. Am J of Clin Nutrition, 2004; 79(6):1118–1125.
Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord. 2003 Jul;27(7):840-7. doi: 10.1038/sj.ijo.0802304. PMID: 12821971.
